ProfileGDS4718 / 222780_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 31% 24% 33% 24% 26% 26% 21% 23% 23% 19% 23% 32% 20% 18% 25% 25% 24% 19% 25% 24% 15% 21% 27% 28% 28% 20% 26% 24% 19% 20% 19% 24% 29% 25% 23% 29% 20% 26% 26% 48% 20% 28% 25% 19% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.5695731
GSM549102patient 115, normal, homogenized [OPG study]4.3025224
GSM549104patient 119, normal, homogenized [OPG study]4.6389433
GSM549108patient 138, normal, homogenized [OPG study]4.3568424
GSM549119patient 077, normal, homogenized [OPG study]4.3923826
GSM549133patient 032, cancer, homogenized [OPG study]4.3306226
GSM549139patient 042, cancer, homogenized [OPG study]4.1574321
GSM549099patient 107, normal, homogenized [OPG study]4.2621723
GSM549109patient 139, normal, homogenized [OPG study]4.3017123
GSM549110patient 046, normal, homogenized [OPG study]4.1152319
GSM549114patient 063, normal, homogenized [OPG study]4.2389823
GSM549122patient 082, normal, homogenized [OPG study]4.6227632
GSM549134patient 033, cancer, homogenized [OPG study]4.1499720
GSM549136patient 036, cancer, homogenized [OPG study]4.0338818
GSM549140patient 044, cancer, homogenized [OPG study]4.296925
GSM549111patient 047, normal, homogenized [OPG study]4.306325
GSM549113patient 057, normal, homogenized [OPG study]4.230524
GSM549132patient 031, cancer, homogenized [OPG study]4.0933219
GSM549137patient 038, cancer, homogenized [OPG study]4.3170225
GSM549142patient 047, cancer, homogenized [OPG study]4.389424
GSM549100patient 110, normal, homogenized [OPG study]3.9539415
GSM549107patient 135, normal, homogenized [OPG study]4.1422921
GSM549115patient 068, normal, homogenized [OPG study]4.3550327
GSM549116patient 072, normal, homogenized [OPG study]4.4579928
GSM549120patient 078, normal, homogenized [OPG study]4.4603128
GSM549131patient 030, cancer, homogenized [OPG study]4.0919620
GSM549118patient 074, normal, homogenized [OPG study]4.3587726
GSM549129patient 027, cancer, homogenized [OPG study]4.3032724
GSM549123patient 088, normal, homogenized [OPG study]4.111319
GSM549124patient 006, cancer, homogenized [OPG study]4.1682920
GSM549126patient 015, cancer, homogenized [OPG study]4.0946619
GSM549128patient 025, cancer, homogenized [OPG study]4.2703524
GSM549103patient 117, normal, homogenized [OPG study]4.563829
GSM549117patient 073, normal, homogenized [OPG study]4.3027425
GSM549138patient 041, cancer, homogenized [OPG study]4.2194623
GSM549141patient 045, cancer, homogenized [OPG study]4.4360229
GSM549130patient 028, cancer, homogenized [OPG study]4.1769720
GSM549101patient 111, normal, homogenized [OPG study]4.3944126
GSM549105patient 128, normal, homogenized [OPG study]4.4053926
GSM549106patient 134, normal, homogenized [OPG study]5.3723748
GSM549112patient 048, normal, homogenized [OPG study]4.1449720
GSM549125patient 011, cancer, homogenized [OPG study]4.4838228
GSM549127patient 024, cancer, homogenized [OPG study]4.327425
GSM549135patient 035, cancer, homogenized [OPG study]4.0681519